207 related articles for article (PubMed ID: 8564229)
1. The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.
Chapman V; Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1995 Sep; 116(1):1628-34. PubMed ID: 8564229
[TBL] [Abstract][Full Text] [Related]
2. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
3. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.
Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1996 Jun; 118(3):671-80. PubMed ID: 8762093
[TBL] [Abstract][Full Text] [Related]
4. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
Honoré P; Chapman V; Buritova J; Besson JM
Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
[TBL] [Abstract][Full Text] [Related]
5. Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat.
Buritova J; Honoré P; Chapman V; Besson JM
Pain; 1996 Mar; 64(3):559-568. PubMed ID: 8783322
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
7. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat?
Honoré P; Chapman V; Buritova J; Besson JM
Brain Res; 1995 Dec; 705(1-2):91-6. PubMed ID: 8821738
[TBL] [Abstract][Full Text] [Related]
8. The contribution of GABAB receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat.
Buritova J; Chapman V; Honoré P; Besson JM
Neuroscience; 1996 Jul; 73(2):487-96. PubMed ID: 8783264
[TBL] [Abstract][Full Text] [Related]
9. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression.
Honoré P; Chapman V; Buritova J; Besson JM
Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361
[TBL] [Abstract][Full Text] [Related]
10. Carrageenan oedema and spinal Fos-LI neurones are reduced by piroxicam in the rat.
Buritova J; Honoré P; Chapman V; Besson JM
Neuroreport; 1995 Jul; 6(10):1385-8. PubMed ID: 7488730
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation.
Honoré P; Buritova J; Besson JM
Pain; 1995 Dec; 63(3):365-375. PubMed ID: 8719538
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
Buritova J; Besson JM
Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat.
Chapman V; Honoré P; Buritova J; Besson JM
Neuroscience; 1995 Aug; 67(3):731-9. PubMed ID: 7675199
[TBL] [Abstract][Full Text] [Related]
14. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
15. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin.
Honoré P; Buritova J; Besson JM
Eur J Pharmacol; 1995 Jan; 272(2-3):249-59. PubMed ID: 7713169
[TBL] [Abstract][Full Text] [Related]
16. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat.
Buritova J; Honoré P; Besson JM
Pain; 1996 Oct; 67(2-3):379-89. PubMed ID: 8951933
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
[TBL] [Abstract][Full Text] [Related]
19. UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
Honoré P; Buritova J; Chapman V; Besson JM
Pain; 1998 Apr; 75(2-3):281-93. PubMed ID: 9583764
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
